Meta-analysis evaluating risk of hyperkalemia strati�ed by baseline mra usage in patients with heart failure receiving sglt2 inhibitors

HIGHLIGHTS

• who: Posted Date January and collaborators from the w University of have published the research work: Meta-Analysis Evaluating Risk of Hyperkalemia Stratiufffded by Baseline MRA Usage in Patients with Heart Failure Receiving SGLT2 Inhibitors, in the Journal: (JOURNAL)
• future: While sensitivity analysis yielded no significant reduction in the risk of mild hyperkalemia in both MRA and non-MRA users the consistent trend towards reduction in mild hyperkalemia may harbor important clinical implications and future trials investigating the same may potentially affirm a significant beneficial effect of concomitant MRA and SGLT2is therapy in this regard . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.